ICM Asset Management’s Apyx Medical APYX Stock Holding History

ICM Asset Management’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-11,830	Closed	-$40K	–	50
2017 Q3	$40K	Buy	+11,830	New	+$30.5K	0.05%	51

Other funds holding APYX

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Horizon Kinetics New York $3.06B AUM 5.37% 1-Year Est. Return

Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

ICM Asset Management's APYX Position: Q4 2017 in Review

ICM Asset Management sold out of Apyx Medical (APYX) in Q4 2017, closing a stake of 11,830 shares — an estimated $40K sold.

ICM Asset Management first reported a position in APYX in Q3 2017 and held it in 1 quarter. The position peaked at $40K in Q3 2017. 41 funds tracked by Wall St. Rank hold APYX as of Q4 2017.

ICM Asset Management reported no remaining Apyx Medical position as of Q4 2017 after selling out during the quarter.
ICM Asset Management sold 11,830 Apyx Medical shares in Q4 2017, an estimated $40K.
ICM Asset Management first reported a position in Apyx Medical in Q3 2017 and held it in 1 quarter.
ICM Asset Management's Apyx Medical position peaked at $40K in Q3 2017.
41 funds tracked by Wall St. Rank held Apyx Medical as of Q4 2017.

Based on ICM Asset Management's 13F filing for Q4 2017, filed 15 Feb 2018.